Enovis ENOV
NYSE ENOV
$18.62 -0.41 (-2.15%)
As of: Sep 10, 2026 · 10:00 AM EDT

Enovis (ENOV) Net Income towards Common Stockholders (2010 - 2026)

Enovis' (ENOV) quarterly Net Income towards Common Stockholders came in at -$1.0 million in Q3 2026, up 97.17% year-over-year from -$525447.2 in Q3 2025, and up 87.74% quarter-over-quarter from -$8.4 million in Q2 2026.

Analysis

Enovis (ENOV) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends

Enovis (ENOV) has reported Net Income towards Common Stockholders for 17 consecutive years, with -$1.0 million the latest figure, recorded in Q3 2026.

  • On a quarterly basis, Net Income towards Common Stockholders rose 97.17% year-over-year to -$1.0 million in Q3 2026; TTM through Jul 2026 was -$1.1 billion, a 33.16% decrease from a year earlier, with the FY2025 full-year figure at -$1.2 billion, down 43.5% from the prior year.
  • Net Income towards Common Stockholders was -$1.0 million for Q3 2026 at Enovis, up from -$8.4 million in the prior quarter.
  • Over five years, Net Income towards Common Stockholders peaked at $77.0 million in Q3 2022 and troughed at -$703.2 million in Q4 2024.
  • A 5-year average of -$114.6 million and a median of -$27.2 million in 2023 frame the typical range for Net Income towards Common Stockholders.
  • Across the five-year window, Net Income towards Common Stockholders jumped 168.78% in 2022 and plunged 22931.17% in 2024, its largest moves.
  • Over 5 years, Net Income towards Common Stockholders stood at -$38.6 million in 2022, then surged by 107.98% to $3.1 million in 2023, then sank by 22931.17% to -$703.2 million in 2024, then rose by 25.99% to -$520.5 million in 2025, then jumped by 99.8% to -$1.0 million in 2026.
  • The last three Net Income towards Common Stockholders figures came in at -$1.0 million (Q3 2026), -$8.4 million (Q2 2026), and -$520.5 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 182.70 Bn 177.10 Bn 7.27 Bn 928.00 Mn
2 Intuitive Surgical 126.82 Bn 121.60 Bn 1.96 Bn 823.20 Mn
3 Medtronic 117.93 Bn 109.11 Bn 6.34 Bn 1.48 Bn
4 Stryker 104.83 Bn 101.36 Bn 4.50 Bn 1.28 Bn
5 Boston Scientific 64.79 Bn 64.25 Bn 3.85 Bn 907.00 Mn
6 Edwards Lifesciences 49.83 Bn 45.58 Bn 1.35 Bn 241.40 Mn
7 Alcon 32.99 Bn 31.53 Bn 1.68 Bn -
8 Dexcom 32.14 Bn 30.20 Bn 830.00 Mn 249.10 Mn
9 Steris 20.75 Bn 20.27 Bn 684.20 Mn 201.00 Mn
10 Enovis 1.07 Bn 1.06 Bn 359.25 Mn -1.04 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 3, 2026 -1.04 Mn
Apr 3, 2026 -8.45 Mn
Dec 31, 2025 -520.45 Mn
Oct 3, 2025 -570.91 Mn
Jul 4, 2025 -36.55 Mn
Apr 4, 2025 -55.71 Mn
Dec 31, 2024 -703.20 Mn
Sep 27, 2024 -31.26 Mn
Jun 28, 2024 -18.51 Mn
Mar 29, 2024 -71.84 Mn
Dec 31, 2023 3.08 Mn
Sep 29, 2023 -2.84 Mn
Jun 30, 2023 -9.81 Mn
Mar 31, 2023 -23.16 Mn
Dec 31, 2022 -38.57 Mn
Sep 30, 2022 -66.48 Mn
Jul 1, 2022 76.99 Mn
Apr 1, 2022 15.07 Mn
Dec 31, 2021 -570,000.00
Oct 1, 2021 25.85 Mn